Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration.
about
Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for ProteoglycansMethods for culturing retinal pigment epithelial cells: a review of current protocols and future recommendationsAlternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injuryRPE necroptosis in response to oxidative stress and in AMDMethylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction.Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularizationInhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular InjuryControversial view of a genetically altered mouse model of focal retinal degeneration.Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).Oxidative stress, innate immunity, and age-related macular degenerationDrusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration.Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular DegenerationApigenin Attenuates Oxidative Injury in ARPE-19 Cells thorough Activation of Nrf2 Pathway.Proinflammatory cytokines decrease the expression of genes critical for RPE functionDry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.Reductive carboxylation is a major metabolic pathway in the retinal pigment epithelium.Common cell biologic and biochemical changes in aging and age-related diseases of the eye: toward new therapeutic approaches to age-related ocular diseasesMetallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.Dietary modification and supplementation for the treatment of age-related macular degeneration.The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.The effects of alpha lipoic acid in preventing oxidative stress-induced retinal pigment epithelial cell injury.Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration.Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse.Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9.Cadherins in the retinal pigment epithelium (RPE) revisited: P-cadherin is the highly dominant cadherin expressed in human and mouse RPE in vivo.Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.Protective Effect of Melatonin against Oxidative Stress-Induced Apoptosis and Enhanced Autophagy in Human Retinal Pigment Epithelium Cells
P2860
Q26738776-1BAB087C-90AB-4774-B97A-C99C85BC7D44Q26738931-14070D58-9331-4156-927C-1229F0AA231AQ27311630-3BE374D8-9EAA-4070-9CD6-7008CDDA1580Q27693234-F5D86083-70C8-4604-948A-4517C8F12B45Q30389325-F3EA5AA4-54FF-4A37-9621-723F478EDAC9Q34991275-665E96A2-819C-48E0-A1D3-C7E06C4EF5C9Q35119433-CE3A5962-5B66-49CA-B04C-AF71D552D468Q36791083-876AF782-EBEF-4026-A684-958885F7BE3FQ36891992-FCF37033-ACDE-4634-A1EB-45E0CDC35841Q36933119-60BE5756-4FC8-47A5-A462-EA2B6247AD79Q36940296-CE3077DE-2ED4-4FE6-8FE4-A091F2209A06Q37107078-4FC87BA0-E868-4B4A-A3FD-A4A3032BAB0BQ37218617-9CD71980-E800-46E6-8A14-D9CD938D5DA2Q37253965-C39470E2-A46D-4075-9CED-B2F567A3E756Q37320997-49405957-1A6C-425D-92E2-84ED4AA30D86Q37395303-66C007EA-E1EE-4A4C-9CA5-28420D22AFFCQ37534139-19280FF5-6109-46C6-B46F-858DB54ED8D0Q38170996-9FA86AB0-69E1-4E37-AA1B-94BA80235DB4Q38178092-020935AD-BA11-47D0-B1BD-43573561DD08Q38529695-131736E4-56E7-4109-99BB-D7CB89786589Q38692816-5C27AA02-CBB9-4B8A-BBC2-09F9378BFEC4Q38960651-6C8C6146-9894-475D-8AF4-0B97023965FDQ39244149-471D52A5-7E8B-47AD-AC53-71A981C8E0DAQ40812272-F9D2EB8B-6762-4025-B157-4887D7B5C335Q42481764-CCB0B98E-6B39-46ED-93F7-BC0A9DB836C8Q48235080-FD3459B2-11AA-4DD0-8A89-AD5E39336F0CQ49223108-7209C67C-95B5-49C5-BC9A-5ECEE351A7E7Q58800107-63B1E3B7-8B4B-4E3F-8A52-8B47A01BC07B
P2860
Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Retinal pigment epithelium res ...... -related macular degeneration.
@en
type
label
Retinal pigment epithelium res ...... -related macular degeneration.
@en
prefLabel
Retinal pigment epithelium res ...... -related macular degeneration.
@en
P2093
P1476
Retinal pigment epithelium res ...... -related macular degeneration.
@en
P2093
Albert R Wielgus
Priyatham S Mettu
Sally S Ong
Scott W Cousins
P304
P356
10.1016/J.MAM.2012.04.006
P577
2012-05-03T00:00:00Z